The cannabinoid system: A role in both the homeostatic and hedonic control of eating?

British Journal of Nutrition

Volumn 90, Issue 4, 2003, Pages 729-734

  Harrold, Joanne A ^a   Williams, Gareth ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

2 Arachidonoyl glycerol; Anandamide; Endocannabinoids; Food intake; Obesity; Reward; SR 141716

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ALCOHOL; ANANDAMIDE; ANANDAMIDE DERIVATIVE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DRONABINOL; ENDOCANNABINOID DERIVATIVE; ENZYME; GASTROINTESTINAL HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; LEPTIN; NALOXONE; NEUROPEPTIDE Y; NEUROTRANSMITTER UPTAKE INHIBITOR; OLEAMIDE; OLEIC ACID; OPIATE ANTAGONIST; PROTEIN FOS; RIMONABANT; SR 144258; SUCROSE; UNCLASSIFIED DRUG; UNINDEXED DRUG; DRUG RECEPTOR; ENDOCANNABINOID; UNSATURATED FATTY ACID;

APPETITE; BODY WEIGHT; CACHEXIA; CLINICAL TRIAL; DRUG HALF LIFE; DRUG POTENTIATION; EATING DISORDER; EATING HABIT; ENERGY BALANCE; FEEDING; FOOD INTAKE; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; REVIEW; ANIMAL; EATING; ENERGY METABOLISM; METABOLISM; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; RAT; REWARD; WISTAR RAT;

CANNABIS;

ANIMALS; APPETITE REGULATION; CACHEXIA; CANNABINOIDS; EATING; ENDOCANNABINOIDS; ENERGY METABOLISM; FATTY ACIDS, UNSATURATED; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; LEPTIN; OBESITY; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REWARD;

EID: 0141975204     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN2003942     Document Type: Review

References (53)

1. Adams IB, Compton DR & Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in ratbrain. J Pharmacol Exp Ther 284, 1209-1217.
2. Arnone M, Maruani J, Chaperon F, et al. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132, 104-106.
3. Ben-Shabat S, Fride E, Sheskin T, et al. (1998) An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol 353, 23-31.
4. 1 receptor agonist SR 141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 63, 908-914.
5. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S & Di Marzo V (2001) Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brains levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 98, 6402-6406.
6. Boger DL, Sato H, Lerner AE, Guan X & Gilula NB (1999) Arachidonic acid amide inhibitors of gap junction cell-cell communication. Bioorg Med Chem Lett 9, 1151-1154.
7. Boger DL, Sato H, Lerner AE, et al. (2000) Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci USA 97, 5044-5049.
8. Breivogel CS, Sims LJ & Childers SR (1997) Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J Pharmacol Exp Ther 282, 1632-1642.
9. Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M & Piomelli D (1997) Inhibition of intestinal motility by anandamide, an endogenous cannabinoid. Eur J Pharmacol 340, R7-R8.
10. Colombo G, Agabio R, Diaz G, Lobina C, Reali R & Gessa GL (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63, 113-117.
11. Corp ES, Melville LD, Greenberg D, Gibbs J & Smith GP (1990) Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors. Am J Physiol 259, R317-R323.
12. Cravatt BF, Demarest K, Patricelli MP, et al. (2001) Supersensitivity to anandamide and enhanced cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98, 9371-9376.
13. Croci T, Manara L, Aureggi G, et al. (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125, 1393-1395.
14. Day TA, Rakhshan F, Deutsch DG & Barker EL (2001) Role of fatty acid amidehydrolase in the transport of the endogenous cannabinoid anandamide. Mol Pharmacol 59, 1369-1375.
15. Devane WA, Hanus L, Breuer A, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
16. Di Marzo V, Goparaju SK, Wang L, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825.
17. Di Marzo V, Melck D, Bisogno T & De Petrocellis L (1998a) Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21, 521-528.
18. Di Marzo V, Sepe N, De Petrocellis L, et al. (1998b) Trick or treat from endocannabinoids. Nature 396, 636-637.
19. Finkelstein DI, Reeves AK & Horne MK (1996) An electron microscopic tracer study of the projections from the entopeduncular nucleus to the ventrolateral nucleus of the rat. Neurosci Lett 211, 33-36.
20. Fulton S, Woodside B & Shizgal P (2000) Modulation of brain reward circuitry by leptin. Science 287, 125-128.
21. Giuffrida A, Beltramo M & Piomelli D (2001) Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology. J Pharmacol Exp Ther 298, 7-14.
22. Glass M, Dragunow M & Faull RLM (1997) Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77, 299-318.
23. Gómez R, Navarro M, Ferrer B, et al. (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22, 9612-9617.
24. Gorbachevskaia AL (1999) Projections from the substantia nigra, ventral tegmental area and amygdala to the pallidium in dog brain. Morfologiia 115, 11-14.
25. Hanus L, Abu-Lafi S, Fride E, et al. (2001) 2-arachidonyl glycerol ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 98, 3662-3665.
26. Hao S, Avraham Y, Mechoulan R & Berry EM (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur J Pharmacol 392, 147-156.
27. Harrold JA, Elliott JC, King PJ, Widdowson PS & Williams G (2002) Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: A role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 952, 232-238.
28. Harrold JA, Williams G & Widdowson PS (2000) Early leptin response to a palatable diet predicts dietary obesity in rats: Key role of melanocortin-4 receptors in the ventromedial hypothalamic nucleus. J Neurochem 74, 1224-1228.
29. Hohmann AG & Herkenham M (1999) Localization of central cannabinoid receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study. Neuroscience 90, 923-931.
30. Iverson LL (2000) The Science of Marijuana. Oxford: Oxford University Press.
31. Izzo AA, Mascolo N, Capasso R, Germano MP, De Pasquale R & Capasso F (1999) Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn Schmiedebergs Arch Pharmacol 360, 221-223.
32. Jamshidi N & Taylor DA (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134, 1151-1154.
33. Kirkham TC & Williams CM (2001) Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacology 153, 267-270.
34. Kirkham TC, Williams CM, Fezza F & Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136, 550-557.
35. Ledent C, Valverde O, Cossu G, et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401-404.
36. Mechoulam R & Fride E (2001) A hunger for cannabinoids. Nature 410, 763-764.
37. Mechoulam R, Fride E, Hanus L, et al. (1997) Anandamide may mediate sleep induction. Nature 389, 25-26.
38. Patel NA, Moldow RL, Patel JA, Wu G & Chang SL (1998) Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. Brain Res 797, 225-233.
39. Pecina S & Berridge KC (2000) Opioid sites in nucleus accumbens shell mediate eating and hedonic 'liking' for food: Map based on microinjection Fos plumes. Brain Res 863, 71-86.
40. Rodríguez De Fonseca F, Carrera MR, Navarro M, Koob GF & Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276, 2050-2054.
41. Rodríguez De Fonseca F, Navarro M, Gómez R, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414, 209-212.
42. Romero J, Wenger T, De Miguel R, Ramos JA & Fernandez-Ruiz JJ (1998) Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation. Life Sci 63, 351-356.
43. Simiand J, Keane M, Keane PE & Soubrié P (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmosets. Behav Pharmacol 9, 179-181.
44. Ravinet Trillou CR, Arnone M, Delgorge C, et al. (2003) Anti-obesity effect of SR 141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol 284, R345-R353.
45. Wang L, Liu J, Harvey-White J, Zimmer A & Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100, 1393-1398.
46. Welch SP & Eads M (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 848, 183-190.
47. Welch SP, Huffman JW & Lowe J (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR 141716A. J Pharmacol Exp Ther 286, 1301-1308.
48. Wenger T, Jamali KA, Juaneda C, Leonardelli J & Tramu G (1997) Arachidonylethanolamide (anandamide) activates the parvocellular part of the hypothalamic paraventricular nucleus. Biochem Biophys Res Commun 237, 724-728.
49. Widdowson PS, Upton R, Buckingham R, Arch J & Williams G (1997a) Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes 46, 1782-1785.
50. Widdowson PS, Upron R, Henderson L, Buckingham R, Wilson S & Williams G (1997b) Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Res 774, 1-10.
51. Williams CM & Kirkham TC (1999) Anandamide induces over-eating: Mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143, 315-317.
52. Williams CM, Rogers PJ & Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta 9-THC. Physiol Behav 15, 343-346.
53. Willoughby KA, Moore SF, Martin BR & Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282, 243-247.